NCOA3 and breast carcinoma: ANCO1 also interacts with AIB1 when it is part of the oncogenic TEAD/YAP complex and can repress TEAD/YAP-dependent expression of a number of genes, including those located on the chromosome 1q21.3 cytoband, which is amplified in breast cancer and has been associated with cancer recurrence and poor clinical outcomes [6,15].